1. Computational drug repurposing for primary hyperparathyroidism
   Elif Kubat Öktem et al, 2024, Molecular and Cellular Endocrinology CrossRef
2. Investigation of apoptotic effects of Cucurbitacin D, I, and E mediated by Bax/Bcl‐xL, caspase‐3/9, and oxidative stress modulators in HepG2 cell line
   Muhammed Mehdi Üremiş et al, 2024, Drug Development Research CrossRef
3. Three candidate anticancer drugs were repositioned by integrative analysis of the transcriptomes of species with different regenerative abilities after injury
   Elif Kubat Oktem et al, 2023, Computational Biology and Chemistry CrossRef
4. Targeting Peroxisome Proliferator-Activated Receptor-β/δ, Reactive Oxygen Species and Redox Signaling with Phytocompounds for Cancer Therapy
   Charanjit Kaur et al, 2024, Antioxidants & Redox Signaling CrossRef
5. The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy
   David Standing et al, 2023, Cancers CrossRef
6. Insights into the Role of Oxidative Stress in Ovarian Cancer
   Dan-Ni Ding et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
7. The effective natural compounds for inhibiting Cervical cancer
   Faik Gökalp, 2021, Medical Oncology CrossRef
8. Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK / STAT3 , MAPK / ERK , and AKT / mTOR signaling pathways in HepG2 cell line
   Nuray Üremiş et al, 2022, Journal of Food Biochemistry CrossRef
9. A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma
   Haochen Yu et al, 2022, Aging CrossRef
10. Bryonia aspera Root Extracts Induce Programmed Cell Death in Selected Cell Lines of Glioblastoma, Ovarian, and Breast Cancer
    Fereshteh Bagheri et al, 2024, Journal of Food Biochemistry CrossRef
11. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends
    Hardeep Singh Tuli et al, 2022, Biomolecules CrossRef
12. RETRACTED ARTICLE: Investigating EGFR-VEGF-mediated apoptotic effect of cucurbitacin D and I combination with sorafenib via Ras/Raf/MEK/ERK and PI3K/Akt signaling pathways
    Nuray Üremis et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
13. Cucurbitacin I Reverses Tumor-Associated Macrophage Polarization to Affect Cancer Cell Metastasis
    Xiaocheng Gong et al, 2023, International Journal of Molecular Sciences CrossRef
14. Cucurbitacin-I exhibits anticancer activity by inducing apoptosis in SKOV3 human ovarian cancer cells
    Ji-Won Park et al, 2024, Molecular & Cellular Toxicology CrossRef